Table 1.
Socio-demographic and clinical characteristics of TB/HIV co-infected and HIV-infected patients without TB
| Variables | TB/HIV co-infected patients (n = 97) | HIV-infected patients without TB (n = 455) | P-Value |
|---|---|---|---|
| Age in years, Mean (SD) |
34.5 (9.5) |
33.4 (8.1) |
0.2 |
| Sex |
|
|
|
| Male |
43 (44.3%) |
185 (40.6%) |
0.5 |
| Female |
54 (55.7%) |
270 (59.4%) |
|
| Employment |
|
|
|
| Unemployed |
7 (7.2%) |
52 (11.4%) |
0.2 |
| Employed |
90 (92.8%) |
403 (88.6%) |
|
| Have income source |
|
|
|
| Yes |
69 (71.1%) |
316 (69.5%) |
0.7 |
| No |
28 (28.9%) |
139 (30.5%) |
|
| Have social support |
|
|
|
| Yes |
11(11.3%) |
63 (13.8%) |
0.5 |
| No |
86 (87.7%) |
392 (86.2%) |
|
| WHO staging |
|
|
|
| Stage I |
- |
71(15.6%) |
0.000 |
| Stage II |
- |
64 (14.1%) |
|
| Stage III |
79 (81.4) |
216 (47.5%) |
|
| Stage IV |
18 (18.6%) |
65 (14.2%) |
|
| Mean CD4 lymphocyte count, (median) |
392.6 (375.0) (n = 24) |
383.7 (358.0) (n = 160) |
0.8 |
| Missed at least one dose of anti-TB treatment |
7 (7.2%) |
- |
- |
| Missed at least one dose of ART |
3(3.1) |
7 (1.5%) |
0.535 |
| Lost to follow-up | 27(21%) | 10 (2.2%) | 0.000 |